首页 | 本学科首页   官方微博 | 高级检索  
检索        


The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome
Authors:Email author" target="_blank">Brent?Lee?LechnerEmail author  Detlef?Bockenhauer  Sandra?Iragorri  Thomas?Lyle?Kennedy  Norman?Joseph?Siegel
Institution:(1) Division of Pediatric Nephrology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA;(2) 333 Cedar Street, P.O. Box 208064, New Haven, CT 06520–8064, USA
Abstract:While increased risk of cardiovascular disease (CVD) in patients with hyperlipidemia, chronic kidney disease (CKD), or end-stage renal disease (ESRD) is well documented, transient hyperlipidemia or intermittent renal disease as a consequence of relapsing nephrotic syndrome (NS) has not been studied. To investigate this enigma, 62 patients, between 25 and 53 years of age, who had steroid-responsive/dependent NS during childhood, were identified from the records of the Division of Pediatric Nephrology at Yale School of Medicine. Forty patients were located and contacted to ascertain symptoms or occurrences of CVD via a telephone interview. At the time of follow-up, 23–46 years after cessation of NS, none of these patients had ESRD or CKD. Three patients had experienced a myocardial infarction (MI): a 32-year-old male with a family history of CVD; a 41-year-old male with a history of heavy smoking, hypertension, diabetes mellitus, and elevated cholesterol; a 31-year-old male after a cocaine overdose. The occurrence of events (8%) and mortality from CVD (none) in this cohort of patients is comparable to patients of a similar age in the general population and is lower than that of patients of the same age who are on dialysis. The data suggest that relapsing NS during childhood does not place patients at increased risk for CVD mortality or morbidity compared with the general population. Consequently, it would appear that factors related to persistent proteinuria or renal insufficiency, rather than transient proteinuria and renal disease, contribute to the CVD documented in patients with CKD or ESRD.
Keywords:Nephrosis  Hyperlipidemia  Cholesterol-lowering agents  Corticosteroids  Myocardial infarction
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号